15th Dec 2005 12:00
AstraZeneca PLC15 December 2005 Dealing by Directors Companies Act 1985 Sections 324/329 Transaction by Persons Discharging Managerial Responsibilities Disclosure Rules DR 3.1.2R We hereby inform you that on 14 December 2005 Sir Tom McKillop, a Director ofthe Company, sold 77,774 AstraZeneca PLC USD0.25 Ordinary Shares at a price of2749 pence per share. The sale of these shares at this time by Sir Tom is based on independent,personal financial advice received by him in the context of tax planning for hisretirement from the Board of AstraZeneca PLC at the end of 2005. In order totake full advantage of the taper relief on the capital gain incurred on the saleof these shares, it was necessary for the sale to occur while Sir Tom is stillemployed by the Company. Following this sale, Sir Tom McKillop's total holding in the Company is 119,258shares, which represents approximately 0.008% of the issued ordinary capital ofthe Company. This total includes a conditional entitlement to a target award of104,417 shares granted under the AstraZeneca Performance Share Plan in June2005. Sir Tom also holds options over 678,481 Ordinary Shares in the Companygranted under two executive share option schemes. G H R Musker Company Secretary 15 December 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca